Leader in SLE, RA and Crohn diseases
Our close professional relations with the KIL in the field of rheumatology drove Resbiomed to become a leader in clinical studies on the Balkans
Phase I – Phase Ia clinical studies involving over 25 sites.
Leader in SLE, RA and Crohn diseases
Our close professional relations with the KIL in the field of rheumatology drove Resbiomed to become a leader in clinical studies on the Balkans
Phase I – Phase Ia clinical studies involving over 25 sites.
Download our presentation
Become an investigator